Sepoy-logo
No Result
View All Result
Tuesday, December 5, 2023
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

What is the global state of SARS-CoV-2 seroprevalence in children?

Nicholas by Nicholas
January 3, 2023
in Health
0
What is the global state of SARS-CoV-2 seroprevalence in children?

In a recent study published in eClinicalMedicine, researchers conducted a systematic review to assess global pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence.

Study: SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis. Image Credit: Alyona Shu/Shutterstock
Study: SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis. Image Credit: Alyona Shu/Shutterstock

Background

Coronavirus disease 2019 (COVID-19) vaccinations have been administered across the globe; however, children (individuals aged below 19 years in the present study) continue to be the largest group of unvaccinated individuals across the globe. The emergence of the highly immune-evasive SARS-CoV-2 Omicron VOC (a variant of concern) and its sub-VOCs has increased pediatric COVID-19-induced hospitalizations and critical care requirements in developing and developed nations.

About the study

In the present study, researchers assessed SARS-CoV-2 seroprevalence among children across nations.

Credible international scientific databases such as Embase, PubMed, Scopus, and Web of Science, and preprint servers such as bioRxiv, SSRN, and medRxiv were searched for systematic reviews on SARS-CoV-2 seroprevalence among children between 1 December 2019, and 10 July 2022. There were no language restrictions.

Keywords included ‘2019 novel coronavirus’, ‘COVID-19’, ‘SARS-CoV-2’, ‘antibody’, ‘coronavirus’, ‘serology’, ‘seroprevalence’, ‘pediatric’, ‘student’, ‘children’ and ‘adolescent’. In addition, the initial 10 pages of Google Scholar were searched using the aforementioned search terms and names of WHO nations. Moreover, the team’s screen included studies’ bibliographies and relevant literature reviews to obtain additional records. When available, institutional reports were also reviewed for each nation.

Furthermore, from studies reporting seropositivity for different isotypes of antibodies, the count of children with IgG seropositivity was analyzed. The records were independently evaluated by three different investigators. Using random-effects meta-analyses, pooled seroprevalence estimates were obtained for different WHO (World Health Organization) regions. Associations with SARS-CoV-2 seropositivity and heterogeneity sources were investigated by subgroup analysis and meta-regression analysis.

The team excluded records documenting SARS-CoV-2 seropositivity among adult individuals, records not including systematic reviews or other literature reviews. In addition, records documenting SARS-CoV-2 seroprevalence on the basis of PCR (polymerase chain reaction) analysis, radiological assessments, or case reports and/or case series were excluded from the analysis. Diagnostic SARS-CoV-2 studies and duplicate studies were also excluded.

SARS-CoV-2 serological epidemiology was stratified based on WHO regions (Eastern Mediterranean, Africa, Southeast Asia, Europe, Western Pacific, and America), WHO sub-areas based on COVID-19 mortality; World Bank income categories, HDI (human development index) levels, global COVID-19 waves, bias risks; and method of COVID-19 diagnosis.

SARS-CoV-2 detection methods included LFIA (lateral flow immunoassays), ELISA (enzyme-linked immunosorbent assays), CLIA (chemiluminescence enzyme immunoassays), IFA (immunofluorescence assays), VNA (virus neutralization assays), LMAS (Luminex multi-antigen serology assays), and LLIS (luciferase-linked immunosorbent assays). Bias risks were assessed based on JBI (Joanna Briggs Institute) tools for seroprevalence, cohort, and cross-sectional analytical studies.

Results

In total, 46,702 records were identified initially, including 43,734 database records, 2703 preprint records, and 265 records from Google Scholar and article bibliographies, of which 45,809 records were irrelevant or duplicates and were therefore excluded. After reviewing the full text of 893 records, 247 records (234 and 13 articles and institutional reports, respectively), including 757,075 pediatric individuals across 70 nations, were considered for the final analysis.

Among the studies, low, moderate, and high risk of bias was reported for 148, 112, and 42 records, respectively. Sampling dates for most studies were the end of 2021 (pre-Omicron or Delta dominance period). Most datasets (n=144) used ELISA analysis for SARS-CoV-2 detection, followed by CLIA (n=97), rapid LFIA (n=46), and other methods, including VNA, LMAS, LLIS, and IFA (n=15).

Seroprevalence estimates varied between seven percent in the initial COVID-19 wave and 38% and 57% in the fifth and sixth COVID-19 waves, respectively. The greatest SARS-CoV-2 seroprevalence rates were observed for Southeast Asia (18% to 82%) and Africa (17% to 66%), whereas the rates were the least for the Western Pacific WHO region (0.01% to 1.0%).

Seroprevalence estimates were higher for children aged 10 years to 19 years, for children residing in underprivileged nations and regions (low-income and low HDI regions), and for children belonging to minor ethnicities. There were no statistically significant differences in pediatric SARS-CoV-2 seroprevalence by sex.

COVID-19 wave at the time of sampling, gross nation-scale per capita income, and the study quality were the key heterogeneity sources. Of the 757,075 children analyzed, 131,361 children demonstrated particular anti-SARS-CoV-2 antibodies. The sensitivity analysis findings indicated that the study findings were highly robust.

Conclusion

Overall, the study findings demonstrated that by the end of the year 2021, during Delta VOC dominance, 50.0% to 70.0% of pediatric individuals worldwide showed COVID-19 susceptibility. The findings underscored the need for expanding COVID-19 vaccination programs to pediatric and adolescent individuals, especially those residing in underprivileged regions and belonging to minor ethnic backgrounds.

READ ALSO

Study links brisk walking to lower type 2 diabetes risk

New decision rule can reduce unnecessary head CT scans in older adults after falls

Tags: AntibodiesChildrenCoronavirusCoronavirus Disease COVID-19covid-19Critical CareELISAEnzymeImmunoassaysOmicronRespiratorySARSSARS-CoV-2SerologySevere Acute RespiratorySevere Acute Respiratory SyndromeSyndrome

Related Posts

Study links brisk walking to lower type 2 diabetes risk
Health

Study links brisk walking to lower type 2 diabetes risk

December 4, 2023
New decision rule can reduce unnecessary head CT scans in older adults after falls
Health

New decision rule can reduce unnecessary head CT scans in older adults after falls

December 4, 2023
Does immediate parent-infant skin-to-skin contact improve interaction in very preterm babies at 4 months?
Health

Does immediate parent-infant skin-to-skin contact improve interaction in very preterm babies at 4 months?

December 4, 2023
Navigating STXBP1-related disorders: Unraveling clinical and developmental outcomes
Health

Navigating STXBP1-related disorders: Unraveling clinical and developmental outcomes

December 4, 2023
Gut microbe Lactobacillus found to bolster stress resilience, new study reveals
Health

Gut microbe Lactobacillus found to bolster stress resilience, new study reveals

December 4, 2023
18-month meditation program improves psychological wellbeing in seniors
Health

18-month meditation program improves psychological wellbeing in seniors

December 1, 2023
Next Post
Gallagher acquires Chicago firm

Gallagher acquires Chicago firm

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

POPULAR NEWS

Roblox Is Unbreakable Trello Is this safe?

Roblox Is Unbreakable Trello Is this safe?

November 4, 2022
Discord Registered Games  Discord Registered Gaming You need to join the Club

Discord Registered Games Discord Registered Gaming You need to join the Club

November 4, 2022
How To Chose the Right Data Analytics Program

How To Chose the Right Data Analytics Program

November 4, 2022
Heavy explosion on market square in Halle – three injured

Heavy explosion on market square in Halle – three injured

November 4, 2022

Shivon Zilis Wiki, Height, Age, Boyfriend, Husband, Family, Biography & More

July 11, 2022

EDITOR'S PICK

Peak Re names new chief underwriting officer

August 12, 2022
Forever chemicals: Is PFAS litigation coming to Canada?

Forever chemicals: Is PFAS litigation coming to Canada?

September 19, 2023

Bharat Ganeshpure Wiki, Height, Age, Wife, Children, Family, Biography & More

June 22, 2022

Why you should move to Long Island

July 28, 2022

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: [email protected]

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • TV-Kritik „Hart aber Fair“: So kommen wir nicht ans Ziel
  • Study links brisk walking to lower type 2 diabetes risk
  • Maximize Business Efficiency: Unveiling 5 Benefits of E-Invoicing in Improving Business Performance

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net

x